2,334 Shares in Colgate-Palmolive (NYSE:CL) Bought by Equitable Trust Co.

Equitable Trust Co. acquired a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,334 shares of the company’s stock, valued at approximately $212,000.

Several other hedge funds have also recently bought and sold shares of the company. Chicago Partners Investment Group LLC increased its stake in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at about $1,315,000. Gordian Advisors LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $602,000. Carrera Capital Advisors lifted its holdings in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $4,066,000. 80.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CL shares. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Barclays lowered their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Raymond James reissued an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $101.16.

Get Our Latest Stock Analysis on CL

Colgate-Palmolive Stock Up 1.6 %

Shares of NYSE:CL opened at $87.35 on Wednesday. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The business’s 50-day moving average is $90.14 and its 200-day moving average is $96.69. The company has a market capitalization of $71.37 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm earned $0.87 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.29%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.